Novel Treatment for Patients with Traumatic Brain Injury (TBI)
Abstract
Systemic hypotension independently increases morbidity and mortality after traumatic brain injury. The goal of all treatments is avoid hypotension and maintain cerebral perfusion. If this cannot be achieved with fluids, pressers are required. Unfortunately, refractoriness and other adverse events are common with standard of care catecholamine pressers and there are no FDA-approved alternatives if refractoriness develops or severe adverse events occur during treatment of a brain injured patient. This project was designed to provide an alternative and thereby extend the existing capability of physicians to treat patients with life threatening brain injury.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jun 01, 2016
- Accession Number
- AD1022353
Entities
People
- Kenneth G. Proctor
Organizations
- University of Miami